01.09.2014 Views

Aarkstore.com - Digital Pathology Market by Slide Scanners ,Analytics ,Delivery Modes & by Whole Slide Image Storage- Global Forecasts & Trends to 2018

The European region has gained momentum for digital pathology. Some of the European countries have witnessed successful pathology projects which are likely to lead to higher adoption of digital pathology in these countries. The North American market is expected to grow at a healthy growth rate over the next five years. See Full Report : http://bit.ly/1vW9TgO

The European region has gained momentum for digital pathology. Some of the European countries have witnessed successful pathology projects which are likely to lead to higher adoption of digital pathology in these countries. The North American market is expected to grow at a healthy growth rate over the next five years.

See Full Report : http://bit.ly/1vW9TgO

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

1 st September 2014<br />

<strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> <strong>by</strong> <strong>Slide</strong> <strong>Scanners</strong> (<strong>Whole</strong> <strong>Slide</strong> Imaging),<br />

<strong>Analytics</strong> (<strong>Image</strong> Analysis Software), <strong>Delivery</strong> <strong>Modes</strong> (Web<br />

Based/Cloud Based) & <strong>by</strong> <strong>Whole</strong> <strong>Slide</strong> <strong>Image</strong> <strong>S<strong>to</strong>rage</strong> - <strong>Global</strong><br />

<strong>Forecasts</strong> & <strong>Trends</strong> <strong>to</strong> <strong>2018</strong><br />

The global digital pathology market was valued at an estimated $250.2 million in<br />

2013 and is expected <strong>to</strong> grow at a CAGR of 11.8%, <strong>to</strong> reach an estimated $437 million<br />

<strong>by</strong> <strong>2018</strong>.<br />

In 2013, the North American market was valued at $128.9 million and accounted for<br />

the largest share of the global digital pathology market, followed <strong>by</strong> Europe and Asia.<br />

The North American market is expected <strong>to</strong> grow at a healthy growth rate over the next<br />

five years. This high growth can be attributed <strong>to</strong> the favorable reimbursement scenario<br />

in the U.S. and the use of digital pathology <strong>to</strong> improve the quality of cancer diagnosis<br />

in Canada. However, lack of FDA approvals for digital pathology <strong>to</strong> be used for<br />

primary diagnosis acts as a major barrier for the North American market.<br />

The European region has gained momentum for digital pathology. Some of the<br />

European countries have witnessed successful pathology projects which are likely <strong>to</strong><br />

lead <strong>to</strong> higher adoption of digital pathology in these countries. Furthermore, Europe<br />

hosts various digital pathology conferences that aim <strong>to</strong> bring professionals under one<br />

roof and bring <strong>to</strong> light the ongoing developments in digital pathology. However, the<br />

Asian market, slated at an estimated CAGR of 13.7%, will experience the highest<br />

growth in the digital pathology market. The rise in awareness of digital pathology and<br />

its benefits, collaborative efforts <strong>by</strong> players, and federal health departments<br />

encouraging the use of digital pathology <strong>to</strong> improve the quality of cancer diagnosis are


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

some of the fac<strong>to</strong>rs driving the growth of the Asian market.<br />

The major players in this market include 3DHistech (Hungary), Leica Biosystems<br />

(Germany), Ventana Medical Systems (U.S.), Hamamatsu Pho<strong>to</strong>nics K.K. (Japan),<br />

Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark),<br />

and Indica Labs (U.S.)..<br />

Browse <strong>com</strong>plete Report on :<br />

http://www.aarks<strong>to</strong>re.<strong>com</strong>/healthcare/48513/<strong>Digital</strong>-<strong>Pathology</strong>-<strong>Market</strong>-<strong>by</strong>-<strong>Slide</strong>-<br />

<strong>Scanners</strong>-<strong>Whole</strong>-<strong>Slide</strong>-Imaging<br />

Table of Content:<br />

1 Introduction 19<br />

1.1 Objectives Of The Study 19<br />

1.2 Report Description 19<br />

1.3 <strong>Market</strong>s Covered 20<br />

1.4 Stakeholders 22<br />

1.5 Research Methodology 23<br />

1.5.1 Secondary Research 23<br />

1.5.2 Primary Research 25<br />

1.5.3 Key Data From Primary Sources 26<br />

1.5.4 <strong>Market</strong> Forecast 29


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

1.5.5 <strong>Market</strong> Data Validation And Data Triangulation 31<br />

1.6 Assumptions 32<br />

2 Executive Summary 33<br />

3 <strong>Market</strong> Overview 37<br />

3.1 <strong>Market</strong> Dynamics 3<br />

3.1.1 Drivers 38<br />

3.1.1.1 Rising Prevalence Of Cancer 38<br />

3.1.1.2 Improvement In Lab Efficiency 38<br />

3.1.1.3 Drug Development 38<br />

3.1.1.4 Increasing Use Of Companion Diagnostics 39<br />

3.1.1.5 Ease Of Consultation Enabled By <strong>Digital</strong> <strong>Pathology</strong> 39<br />

3.1.2 Restraints 40<br />

3.1.2.1 High Cost Of <strong>Digital</strong> <strong>Pathology</strong> Systems 40<br />

3.1.2.2 Regula<strong>to</strong>ry Concerns 40<br />

3.1.2.3 Conservative Outlook Of Pathologists 40<br />

3.1.3 Opportunities 41<br />

3.1.3.1 <strong>Digital</strong> <strong>Pathology</strong> To Help Combat The Shortage Of Pathologists 41<br />

3.1.3.2 Affordable <strong>Scanners</strong> For Private <strong>Pathology</strong> Practices 41<br />

3.1.3.3 Biopharmaceutical And Drug Toxicology Studies 42<br />

3.1.3.4 Personalized Medicine 42


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

3.1.3.5 <strong>Digital</strong> <strong>Pathology</strong> To Aid Collaborations Between Asia And The West 42<br />

3.2 <strong>Market</strong> Share Analysis 43<br />

3.2.1 <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong>, By Key Player 43<br />

3.3 Industry Speaks 47<br />

4 <strong>Digital</strong> <strong>Pathology</strong>: Rationale For Adoption 49<br />

4.1 Introduction 50<br />

4.2 Significance Of <strong>Digital</strong> <strong>Pathology</strong> 51<br />

4.2.1 Geographic Distribution Of Pathologists 51<br />

4.2.2 Case Transport 51<br />

4.2.3 Case Review 51<br />

4.2.4 Additional Studies 52<br />

4.2.5 Diagnosis Entry 52<br />

4.2.6 Quality Control 52<br />

4.3 Why A Lab Should Adopt The <strong>Digital</strong> <strong>Pathology</strong> Technology 53<br />

5 <strong>Global</strong> <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong>, By Product 59<br />

5.1 Introduction 60<br />

5.2 <strong>Scanners</strong> 62<br />

5.3 <strong>Analytics</strong> 64<br />

5.3.1 Visualization Software 64<br />

5.3.2 <strong>Digital</strong> <strong>Pathology</strong> Information Management Systems 64


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

5.3.3 <strong>Image</strong> Analysis Platforms 64<br />

5.4 <strong>S<strong>to</strong>rage</strong> 66<br />

5.5 Communication/<strong>Delivery</strong> <strong>Modes</strong> 68<br />

5.5.1 Web-Based 71<br />

5.5.2 Cloud-Based 72<br />

6 <strong>Global</strong> <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong>, By Application 75<br />

6.1 Introduction 76<br />

6.2 Human <strong>Pathology</strong> 78<br />

6.2.1 Pharmaceutical & Biotechnology Companies 80<br />

6.2.2 Hospitals/Reference Labora<strong>to</strong>ries/Academic Medical Centers (Amc) 81<br />

6.2.3 Training And Education 83<br />

6.3 Animal <strong>Pathology</strong> 84<br />

6.3.1 Pharmaceutical & Biotechnology Companies 86<br />

6.3.2 Academic & Government Research Institutes 87<br />

6.3.3 Contract Research Organizations 89<br />

7 <strong>Global</strong> <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong>, By Geography 91<br />

7.1 Introduction 92<br />

7.2 North America 94<br />

7.2.1 U.S. 97<br />

7.2.1.1 Favorable Reimbursement Scenario For <strong>Digital</strong> <strong>Pathology</strong> In The U.S. To<br />

Boost The <strong>Market</strong> 97


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

7.2.2 Canada 99<br />

7.2.2.1 Embracing <strong>Digital</strong> <strong>Pathology</strong> To Improve The Quality Of Healthcare In<br />

Canada 99<br />

7.3 Europe 102<br />

7.3.1 U.K. 106<br />

7.3.1.1 Technological Developments In The U.K. To Propel The <strong>Market</strong> 106<br />

7.3.1.2 Conferences In The U.K. To Boost The <strong>Market</strong> 106<br />

7.3.2 Germany 108<br />

7.3.2.1 Conferences In Germany To Trigger Growth 108<br />

7.3.3 Italy 110<br />

7.3.3.1 Successful <strong>Digital</strong> <strong>Pathology</strong> Projects In Italy 110<br />

7.3.4 France 112<br />

7.3.4.1 Use Of <strong>Digital</strong> <strong>Pathology</strong> In The Pharmaceutical Industry To Boost The<br />

<strong>Market</strong> In France 112<br />

7.3.5 Spain 114<br />

7.3.5.1 Adoption Of <strong>Digital</strong> <strong>Pathology</strong> To Improve Quality Of Healthcare 114<br />

7.3.6 Denmark 116<br />

7.3.6.1 Alarming Rise In Prevalence Of Cancer To Boost The <strong>Market</strong> In Denmark 116<br />

7.3.7 Norway 118<br />

7.3.7.1 <strong>Digital</strong> <strong>Pathology</strong> Revolution In Norway To Propel <strong>Market</strong> Growth 118<br />

7.3.8 Sweden 120


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

7.3.8.1 Conferences In Sweden To Boost The <strong>Market</strong> 120<br />

7.3.8.2 Positive Funding Scenario In Sweden To Focus On Innovation 121<br />

7.3.9 Rest Of Europe (Roe) 122<br />

7.3.9.1 <strong>Digital</strong> <strong>Pathology</strong> Gaining Momentum In The Netherlands 122<br />

7.4 Asia 125<br />

7.4.1 China 128<br />

7.4.1.1 Collaborations In China To Boost <strong>Market</strong> Growth 128<br />

7.4.1.2 Ministry Of Health In China Encourages Use Of <strong>Digital</strong> <strong>Pathology</strong> 128<br />

7.4.2 Japan 130<br />

7.4.2.1 Focus On S<strong>to</strong>mach Cancer Diagnosis To Propel The <strong>Market</strong> In Japan 130<br />

7.4.3 India 132<br />

7.4.3.1 <strong>Digital</strong> <strong>Pathology</strong> Gaining Momentum In India 132<br />

7.4.4 Middle East 134<br />

7.4.4.1 Exhibitions In The Middle East To Increase Awareness Of <strong>Digital</strong> <strong>Pathology</strong><br />

134<br />

7.4.5 Rest Of Asia (Roa) 136<br />

7.4.5.1 Bilateral Agreements Aimed To Increase Awareness Of <strong>Digital</strong> <strong>Pathology</strong> In<br />

Pakistan 136<br />

7.5 Rest Of The World (Row) 139<br />

7.5.1 Latin America 142<br />

7.5.1.1 Players Eyeing Brazil As An Attractive <strong>Market</strong> 142


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

7.5.2 Africa 144<br />

7.5.2.1 Strategies By Key Players To Aid Growth Of <strong>Digital</strong> <strong>Pathology</strong> In Africa 144<br />

7.5.3 Russia 146<br />

7.5.3.1 Increasing Popularity Of <strong>Digital</strong> <strong>Pathology</strong> As A Cost-Effective Solution To<br />

Help Propel The <strong>Market</strong> In Russia 146<br />

7.5.4 Pacific Countries 148<br />

7.5.4.1 Patients In Pacific Countries To Receive Better And Timely Diagnosis Due To<br />

<strong>Digital</strong> <strong>Pathology</strong> 148<br />

8 Competitive Landscape 151<br />

8.1 Introduction 151<br />

8.2 New Product Launches 155<br />

8.3 Agreements, Partnerships, And Collaborations 156<br />

8.4 Acquisitions 158<br />

8.5 Other Developments 159<br />

9 Company Profiles 161<br />

(Overview, Financials, Products & Services, Strategy, & Developments)*<br />

9.1 3dhistech Ltd. 161<br />

9.2 Apollo Pacs, Inc. 166<br />

9.3 Aurora Interactive Ltd. 171<br />

9.4 Corista Llc 174<br />

9.5 Definiens Ag 177


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

9.6 Digipath Inc. 182<br />

9.7 Hamamatsu Pho<strong>to</strong>nics K.K. 186<br />

9.8 Huron Technologies International, Inc. 191<br />

9.9 Indica Labs, Inc. 195<br />

9.10 Kanteron Systems 199<br />

9.11 Leica Biosystems, Gmbh 202<br />

9.12 Ligolab, Llc 208<br />

9.13 Mikroscan Technologies, Inc. 210<br />

9.14 Nikon Instruments, Inc. 213<br />

9.15 Objective <strong>Pathology</strong> Services, Ltd. 216<br />

9.16 Omnyx, Llc 218<br />

9.17 Xifin, Inc. 222<br />

9.18 Pathxl, Ltd. 225<br />

9.19 Pixcelldata, Ltd. 231<br />

9.20 Sunquest Information Systems, Inc. 234<br />

9.21 Ventana Medical Systems, Inc. 238<br />

9.22 Visiopharm 246<br />

*Details On Financials, Product & Services, Strategy, & Developments Might Not Be<br />

Captured In Case Of Unlisted Companies.


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

List Of Tables<br />

Table 1 Typical Labora<strong>to</strong>ry Workflow Steps With Integrated <strong>Digital</strong> Imaging 55<br />

Table 2 <strong>Global</strong> <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 61<br />

Table 3 <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> For <strong>Scanners</strong>, By Region,<br />

2011–<strong>2018</strong> ($Million) 63<br />

Table 4 <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> For <strong>Analytics</strong>, By Region,<br />

Vx2011–<strong>2018</strong> ($Million) 65<br />

Table 5 <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> For <strong>S<strong>to</strong>rage</strong>, By Region,<br />

2011–<strong>2018</strong> ($Million) 67<br />

Table 6 <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> For Communication/<strong>Delivery</strong> <strong>Modes</strong>, By Region,<br />

2011–<strong>2018</strong> ($Million) 69<br />

Table 7 <strong>Global</strong> <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> For Communication/ <strong>Delivery</strong> Mode, By<br />

Type, 2011–<strong>2018</strong> ($Million) 70<br />

Table 8 <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> For Web-Based Communication,<br />

By Region, 2011–<strong>2018</strong> ($Million) 72<br />

Table 9 <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> For Cloud-Based Communication, By Region,<br />

2011–<strong>2018</strong> ($Million) 74<br />

Table 10 <strong>Global</strong> <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 77<br />

Table 11 <strong>Global</strong> Human <strong>Pathology</strong> <strong>Market</strong> Size, By Application,


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

2011–<strong>2018</strong> ($Million) 78<br />

Table 12 Human <strong>Pathology</strong> <strong>Market</strong> Size, By Region, 2011–<strong>2018</strong> ($Million) 79<br />

Table 13 Human <strong>Pathology</strong> <strong>Market</strong> For Pharmaceutical And Biotechnology<br />

Companies, By Region, 2011–<strong>2018</strong> ($Million) 81<br />

Table 14 Human <strong>Pathology</strong> <strong>Market</strong> For Hospitals/Reference Labora<strong>to</strong>ries/Academic<br />

Medical Centers (Amc), By Region, 2011–<strong>2018</strong> ($Million) 82<br />

Table 15 Human <strong>Pathology</strong> <strong>Market</strong> For Training And Education,<br />

By Region, 2011–<strong>2018</strong> ($Million) 83<br />

Table 16 <strong>Global</strong> Animal <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 85<br />

Table 17 Animal <strong>Pathology</strong> <strong>Market</strong> Size, By Region,<br />

2011–<strong>2018</strong> ($Million) 86<br />

Table 18 Animal <strong>Pathology</strong> <strong>Market</strong> For Pharmaceutical & Biotechnology Companies,<br />

By Region, 2011–<strong>2018</strong> ($Million) 87<br />

Table 19 Animal <strong>Pathology</strong> <strong>Market</strong> For Academic And Government Research<br />

Institutes, By Region, 2011–<strong>2018</strong> ($Million) 88<br />

Table 20 Animal <strong>Pathology</strong> <strong>Market</strong> For Contract Research Organizations, By Region,<br />

2011–<strong>2018</strong> ($Million) 90<br />

Table 21 <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Region,<br />

2011–<strong>2018</strong> ($Million) 93<br />

Table 22 North America: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size,<br />

By Product, 2011–<strong>2018</strong> ($Million) 94


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

Table 23 North America: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size,<br />

By Application, 2011–<strong>2018</strong> ($Million) 95<br />

Table 24 North America: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size,<br />

By Country, 2011–<strong>2018</strong> ($Million) 96<br />

Table 25 U.S.: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 98<br />

Table 26 U.S.: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 99<br />

Table 27 Canada: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 100<br />

Table 28 Canada: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 101<br />

Table 29 Europe: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 103<br />

Table 30 Europe: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 104<br />

Table 31 Europe: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Country,<br />

2011–<strong>2018</strong> ($Million) 105<br />

Table 32 U.K.: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 107


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

Table 33 U.K.: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 108<br />

Table 34 Germany: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 109<br />

Table 35 Germany: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application, 2011–<strong>2018</strong><br />

($Million) 110<br />

Table 36 Italy: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 111<br />

Table 37 Italy: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 112<br />

Table 38 France: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 113<br />

Table 39 France: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 114<br />

Table 40 Spain: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 115<br />

Table 41 Spain: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 116<br />

Table 42 Denmark: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 117


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

Table 43 Denmark: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application, 2011–<strong>2018</strong><br />

($Million) 118<br />

Table 44 Norway: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 119<br />

Table 45 Norway: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 120<br />

Table 46 Sweden: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 121<br />

Table 47 Sweden: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 122<br />

Table 48 Roe: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 123<br />

Table 49 Roe: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 124<br />

Table 50 Asia: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 125<br />

Table 51 Asia: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 126<br />

Table 52 Asia: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Country,<br />

2011–<strong>2018</strong> ($Million) 127<br />

Table 53 China: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

2011–<strong>2018</strong> ($Million) 129<br />

Table 54 China: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 130<br />

Table 55 Japan: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 131<br />

Table 56 Japan: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 132<br />

Table 57 India: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 133<br />

Table 58 India: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 134<br />

Table 59 Middle East: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product, 2011–<strong>2018</strong><br />

($Million) 135<br />

Table 60 Middle East: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application, 2011 – <strong>2018</strong><br />

($Million) 136<br />

Table 61 Roa: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 137<br />

Table 62 Roa: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 138<br />

Table 63 Row: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 139


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

Table 64 Row: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 140<br />

Table 65 Row: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Region,<br />

2011–<strong>2018</strong> ($Million) 141<br />

Table 66 Latin America: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size,<br />

By Product, 2011–<strong>2018</strong> ($Million) 142<br />

Table 67 Latin America: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size,<br />

By Application, 2011–<strong>2018</strong> ($Million) 143<br />

Table 68 Africa: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 145<br />

Table 69 Africa: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 146<br />

Table 70 Russia: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2011–<strong>2018</strong> ($Million) 147<br />

Table 71 Russia: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Application,<br />

2011–<strong>2018</strong> ($Million) 148<br />

Table 72 Pacific Countries: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size,<br />

By Product, 2011–<strong>2018</strong> ($Million) 149<br />

Table 73 Pacific Countries: <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size,<br />

By Application, 2011–<strong>2018</strong> ($Million) 150


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

Table 74 New Product Launches, 2011–2014 155<br />

Table 75 Agreements, Partnerships, And Collaborations, 2011–2014 156<br />

Table 76 Acquisitions, 2011–2014 158<br />

Table 77 Other Developments, 2011–2014 159<br />

List Of Figures<br />

Figure 1 Research Methodology 23<br />

Figure 2 Sampling Frame: Primary Research 25<br />

Figure 3 <strong>Market</strong> Size Estimation Methodology 27<br />

Figure 4 <strong>Market</strong> Sizing ($Value Analysis) 28<br />

Figure 5 Competitive Assessment (<strong>Market</strong> Share/Strategy Assessment For <strong>Digital</strong><br />

<strong>Pathology</strong>) 29<br />

Figure 6 <strong>Market</strong> Forecasting Model 30<br />

Figure 7 Data Triangulation Methodology 31<br />

Figure 8 <strong>Global</strong> <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Product,<br />

2013 Vs. <strong>2018</strong> ($Million) 33<br />

Figure 9 <strong>Global</strong> <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size, By Geography,<br />

2013 Vs. <strong>2018</strong> ($Million) 34<br />

Figure 10 <strong>Market</strong> Dynamics 37<br />

Figure 11 <strong>Market</strong> Share Analysis, By Key Player, 2013 44<br />

Figure 12 Labora<strong>to</strong>ry Workflow With Integrated <strong>Digital</strong> Imaging 54


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

Figure 13 <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong>, By Product 60<br />

Figure 14 <strong>Global</strong> <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong> Size For <strong>Scanners</strong>,<br />

2013 Vs. <strong>2018</strong> (Units) 62<br />

Figure 15 <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong>, By Application 76<br />

Figure 16 <strong>Digital</strong> <strong>Pathology</strong> <strong>Market</strong>, Geographical Ranking, 2013 92<br />

Figure 17 Key Growth Strategies, 2011–2014 151<br />

Figure 18 Key Players Focusing On New Product Launches, 2011–2014 152<br />

Figure 19 Key Players Focusing On Agreements, Partnerships, And Collaborations,<br />

2011–2014 153<br />

Related reports:<br />

<strong>Global</strong> Molecular Diagnostics <strong>Market</strong> Report: 2014 Edition<br />

<strong>Global</strong> IV Iron Drugs <strong>Market</strong> Report: 2014 Edition<br />

Healthcare market research<br />

About <strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

<strong>Aarks<strong>to</strong>re</strong> Enterprise is a leading provider of business and financial information and<br />

solutions worldwide. We specialize in providing online market business information<br />

on market research reports, books, magazines, conference at <strong>com</strong>petitive prices, and<br />

strive <strong>to</strong> provide excellent and innovative service <strong>to</strong> our cus<strong>to</strong>mers.


<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

You can order full Report with TOC and Sample page visit<br />

http://www.aarks<strong>to</strong>re.<strong>com</strong>/healthcare/48513/<strong>Digital</strong>-<strong>Pathology</strong>-<strong>Market</strong>-<strong>by</strong>-<strong>Slide</strong>-<br />

<strong>Scanners</strong>-<strong>Whole</strong>-<strong>Slide</strong>-Imaging<br />

Contact Details:<br />

Pranita Roy<br />

<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />

Phone: +91 998 729 5242<br />

Email: enquiry@aarks<strong>to</strong>re.<strong>com</strong><br />

Our Website: http://www.aarks<strong>to</strong>re.<strong>com</strong><br />

Facebook: https://www.facebook.<strong>com</strong>/aarks<strong>to</strong>redot<strong>com</strong><br />

Linkedin: http://www.linkedin.<strong>com</strong>/<strong>com</strong>pany/aarks<strong>to</strong>re-enterprise

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!